PQG Partners have collaborated with IPAC-RS on the production of PS 9000:2011 Pharmaceutical packaging materials to incorporate specific requirements for higher risk applications such as orally inhaled and nasal drug products.

IPAC-RS are an international association of innovator and generic companies that develop, manufacture or market orally inhaled and nasal drug products for local and systemic treatment of a variety of debilitating diseases such as asthma, chronic obstructive pulmonary disease and diabetes.

IPAC-RS are committed to advancing consensus-based, scientifically driven standards and regulations for these products, with the purpose of facilitating the availability of high-quality, safe, and efficacious drug products to patients.